Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE
Anthony Muchai Manyara(University of Bristol), Oriana Ciani(Bocconi University), Philippa Davies(University of Bristol), Sylwia Bujkiewicz(University of Leicester), Joseph S. Ross(Yale University), Dalia Dawoud(Cairo University), An‐Wen Chan(World Health Organization), Mario Ouwens(AstraZeneca (Sweden)), Gary S. Collins(NIHR Birmingham Biomedical Research Centre), Derek Stewart, Nancy J. Butcher(University of Toronto), Amber Young(University of Bristol), Christopher J. Weir(University of Edinburgh), Rod S Taylor(University of Southern Denmark), Martin Offringa(Hospital for Sick Children)
Cited by 21
Related Papers
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal
|BMJ|2020|3.2k
Critical Appraisal and Data Extraction for Systematic Reviews of Prediction Modelling Studies: The CHARMS Checklist
|PLoS Medicine|2014|2k
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
|European Heart Journal|2020|1.8k
Global, regional and national burden of osteoarthritis 1990-2017: a systematic analysis of the Global Burden of Disease Study 2017
|Annals of the Rheumatic Diseases|2020|1.7k